ArticleThe Lancet. Global health2024

Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study.

Cynthia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.